Filtered By:
Management: Marketing
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 200 results found since Jan 2013.
Omega-3 no protection against heart attack or strokes, say scientists
Supplements do not offer cardiovascular benefits, researchers conclude from trials involving 112,000 peopleThe widespread belief that taking omega-3 capsules will help protect you from a heart attack, stroke or early death is wrong, according to a large and comprehensive review of the evidence.Thousands of people take omega-3 supplements regularly and for years. The belief that it protects the heart has spread – and is promoted in the marketing of the supplements – because the results from early trials suggested the capsules had cardiovascular benefits.Continue reading...
Source: Guardian Unlimited Science - July 17, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Health Medical research Food & drink Heart attack Stroke Science Life and style Society Source Type: news
Dynatronics taps ex-NinePoint CEO von Jako as chief exec | Personnel Moves – July 11, 2018
Dynatronics said late last month it tapped former NinePoint Medical CEO Christopher von Jako as its new chief executive officer and board member, succeeding Kelvyn Cullimore Jr. who will stay on the company’s board of directors.
Prior to joining Dynatronics, von Jako acted as prez & CEO of NinePoint Medical. Before joining Nine Point, von Jako also served as prez & CEO of NeuroTherm, prez of ActiViews and held positions with medtech companies including Integra LifeSciences, Covidien and Medtronic.
“After thorough succession planning and a comprehensive search process, the board is pleased to have foun...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News AngioDynamics berkshiresterilemanufacturing Corindus Vascular Robotics Dynatronics Corp Guerbet integer MedPlast Medtronic Myomo Inc NinePoint Medical Inc. Pavmed viant Source Type: news
Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes Of Interest- An Empirical Evaluation.
Abstract
Use of disease risk score (DRS)-based confounding adjustment when estimating treatment effects on multiple outcomes is not well studied. Using an empirical example comparing dabigatran versus warfarin on ischemic stroke and major bleeding risk in 12 sequential monitoring periods (90 days each) using the Truven Marketscan database, we compared two approaches for combining DRS for multiple outcomes: (1) 1:1 matching on prognostic propensity scores (PPS), created using DRS for bleeding and stroke as independent variables in a propensity score (PS) model; and (2) simultaneous 1:1 matching on DRS for bleeding ...
Source: Am J Epidemiol - June 26, 2018 Category: Epidemiology Authors: Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ Tags: Am J Epidemiol Source Type: research
MicroVention Announces FDA Clearance For Thrombectomy Device
SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke
ALISO VIEJO, Calif., June 12, 2018 -- (Healthcare Sales & Marketing Network) -- MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurova... Devices, Interventional, Neurology, FDA MicroVention, Terumo, SOFIA Catheter, stroke
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news
Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer
Industry veteran brings extensive experience driving revenue growth while enhancing operational efficiencies and market leadership
TORONTO and BOSTON, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL) (&... Devices, Orthopaedic, Personnel Bionik Laboratories, lower extremity rehabilitation, stroke
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news
Effect of Energy Drink Consumption on Power and Velocity of Selected Sport Performance Activities
Jacobson, BH, Hester, GM, Palmer, TB, Williams, K, Pope, ZK, Sellers, JH, Conchola, EC, Woolsey, C, and Estrada, C. Effect of energy drink consumption on power and velocity of selected sport performance activities. J Strength Cond Res 32(6): 1613–1618, 2018—Energy drinks (ED) comprise a multibillion dollar market focused on younger, active, and competitive individuals. Marketing includes claims of improved alertness and performance. The purpose of this study was to assess power (W) and velocity (m·s−1) of a simulated, isolated forehand stroke (FHS), and a countermovement vertical jump (CVJ) before and after ingestio...
Source: Journal of Strength and Conditioning Research - May 23, 2018 Category: Sports Medicine Tags: Original Research Source Type: research
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow
IRVINE, Calif., May 21, 2018 -- (Healthcare Sales & Marketing Network) -- CERENOVUS, part of the Johnson & Johnson Medical Devices Compa... Devices, Interventional, Radiology, Neurology, FDA CERENOVUS, Johnson & Johnson, EMBOTRAP, Revascularization, thrombectomy
Source: HSMN NewsFeed - May 21, 2018 Category: Pharmaceuticals Source Type: news
Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System
Company's rental program limits upfront expenditures for hospitals and provides them with greater financial flexibility and maximum ROI
TORONTO and BOSTON, May 16, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL... Devices Bionik Laboratories, stroke, InMotion Arm Therapy
Source: HSMN NewsFeed - May 16, 2018 Category: Pharmaceuticals Source Type: news
Marketing and Opioid Scripts; CBT and Migraine; Cancer Diagnosis and Stroke
(MedPage Today) -- News and commentary from the world of neurology and neuroscience
Source: MedPage Today Psychiatry - May 15, 2018 Category: Psychiatry Source Type: news
AI Solutions Continue to Catch FDA & #039;s Eye
FDA has given a nod to yet another artificial intelligence (AI)-based technology. This time the agency has granted a De Novo request to market IDx’s AI-based diagnostic system for the autonomous detection of diabetic retinopathy, which can lead to blindness.
The Coralville IA-based company’s IDx-DR diagnostic received expedited review under the FDA's Breakthrough Devices program.
Earlier this year, the company told MD+DI that it met its endpoints in a pivotal trial of the IDx-DR system. The trial involved 900 diabetes patients at 10 sites. The study was designed to evaluate the diagnostic accuracy of the technology in ...
Source: MDDI - April 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news
Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.
OXFORD, England, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Brainomix, a medical imaging company using a... Devices, Neurology, Venture Capital Brainomix, Boehringer Ingelheim, stroke, e-ASPECTS
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news
Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
Gains substantial strategic and operational experience within the equity capital markets and the healthcare industry
TORONTO and BOSTON, March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL) ("Bionik&q... Devices, Neurology, Personnel Bionik Laboratories, lower extremity rehabilitation, stroke
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
senfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ, Standardized Data Collection for Cardiovascular Trials Initiative (SCTI)
Abstract
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug Administration (FDA). The FDA established the Standardized Data Collection for Cardiovascular Trials Initiative in 2009 to simplify the design and conduct of clinical trials in...
Source: Circulation - February 27, 2018 Category: Cardiology Authors: Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, R Tags: Circulation Source Type: research
Viz.ai ’s stroke-detecting CDS app receives FDA nod
The FDA announced yesterday that it will permit marketing of Viz.ai ’s Contact, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke.
Source: mobihealthnews - February 14, 2018 Category: Information Technology Source Type: news
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
Tokyo, Japan, February 14, 2018 --(Healthcare Sales & Marketing Network)-- SanBio, Inc. and Teijin Limited jointly announced today that they would terminate the exclusive licensing agreement signed in 2009 regarding the development and marketing of SB623 f... Biopharmaceuticals, Neurology, Licensing Teijin Limited, SanBio Inc, stroke
Source: HSMN NewsFeed - February 14, 2018 Category: Pharmaceuticals Source Type: news
